Abtin Doroudinia
Overview
Explore the profile of Abtin Doroudinia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jadvar H, Doroudinia A, Conti P, Colletti P
Br J Radiol
. 2025 Jan;
PMID: 39873742
Theranostics has its roots with the first radioiodine therapy for thyroid diseases in about 80 years ago. More recently the field has experienced a remarkable renascence with the regulatory approval...
2.
Doroudinia A, Wolfe T
Clin Nucl Med
. 2024 Dec;
50(1):e41-e42.
PMID: 39626293
Although 18F-FDG PET/CT scan is not the preferred modality to evaluate prostate cancer patients due to generally low uptake of FDG in prostate cancer cells, it can still be helpful...
3.
Behnam-Manesh H, Doroudinia A, Bayat M, Bakhshayesh Karam M, Salimi B, Nejabat M, et al.
Clin Nucl Med
. 2023 Nov;
49(1):e40-e41.
PMID: 37976528
Radiolabeled fibroblast activation protein inhibitors (FAPIs) have been extensively used in different types of cancers, although not yet FDA approved. Normal patterns of FAPI biodistribution have been investigated, and it...
4.
Doroudinia A, Chekuri S
Clin Nucl Med
. 2023 Sep;
48(11):e547-e548.
PMID: 37756469
18 F-FDG PET/CT scan is a well-known modality to assess distant metastases and treatment response in the patients with primary colon cancer. We are presenting an interesting case of 68...
5.
Bayat M, Doroudinia A, Bakhshayesh Karam M, Mehrian P
Clin Nucl Med
. 2022 Oct;
48(3):271-272.
PMID: 36252811
Immune checkpoint inhibitors are a new and different treatment option in many of solid tumors, but with many recognized immune-related adverse side effects. In this interesting image, we are presenting...
6.
Doroudinia A, Bakhshayesh Karam M, Ghadimi N, Yousefi F
Clin Nucl Med
. 2022 Feb;
47(5):e399-e400.
PMID: 35175943
FDG PET/CT scan is a diagnostic imaging modality for oncologic patients, but with false-positive findings in inflammatory diseases. In this interesting case, we present a 24-year-old woman with history of...
7.
Doroudinia A, Emami H, Hosseini M
Asia Ocean J Nucl Med Biol
. 2022 Jan;
10(1):14-19.
PMID: 35083345
Objevtives: Neuroendocrine tumors are a heterogeneous group of neoplasms that arise from the peptide-producing cells of the neuroendocrine system. Different functional imaging methods have been suggested to diagnose NETs. There...
8.
Doroudinia A, Bakhshayesh Karam M, Yousefi F, Ghadimi N
Clin Nucl Med
. 2022 Jan;
47(3):e304-e305.
PMID: 35025810
We present a 37-year-old man with cough and progressive dyspnea for the past 3 years. According to inconclusive chest CT scan and lung biopsy histopathology findings, the patient referred for...
9.
Doroudinia A, Safarpour Lima B, Bakhshayesh Karam M, Ghadimi N, Yousefi F
Clin Nucl Med
. 2021 Aug;
47(2):e190-e191.
PMID: 34392290
We are presenting a 22-year-old man with intractable seizures. Autoimmune epilepsy, vasculitis, and paraneoplastic disorder were among initial differential diagnoses. His initial laboratory tests and toxicology screen were unremarkable. His...
10.
Shadmehr M, Khosravi A, Abbasi Dezfouli A, Bakhshayesh-Karam M, Jamaati H, Doroudinia A, et al.
Tanaffos
. 2021 Apr;
19(3):186-194.
PMID: 33815538
Background: An initial evaluation of non-small cell lung cancer (NSCLC) patients with 18F- fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan can modify treatment planning. We investigated the clinical significance...